Significance of PD-L1 expressing tumor cells in the combined positive score with triple negative breast cancer

被引：0
|
作者：
Evans, Tiffany [1 ]
Hund, Stephanie [1 ]
Krohn, Darlene [1 ]
Emancipator, Kenneth [2 ]
Juco, Jonathon [2 ]
Portier, Bryce [1 ]
Tabuena-Frolli, Siena [1 ]
Kulangara, Karina [1 ]
机构：
[1] Agilent, Carpinteria, CA USA
[2] Merck Sharp & Dohme Corp, Kenilworth, NJ USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS4-15
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-L1 expression in Triple Negative Breast Cancer: a study of an Iraqi population
    Keorges, Gina James
    JOURNAL OF MEDICAL SCIENCE, 2023, 92 (01): : 81 - 85
  • [22] The risk of PD-L1 expression misclassification in triple-negative breast cancer
    Ben Dori, Shani
    Aizic, Asaf
    Zubkov, Asia
    Tsuriel, Shlomo
    Sabo, Edmond
    Hershkovitz, Dov
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 297 - 305
  • [23] Correlation of PD-L1 Protein and mRNA Expression in triple negative Breast Cancer
    Schueler
    Bauer, M.
    Kaufhold, S.
    Kantelhardt, E. J.
    Thomssen, C.
    Vetter, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (06) : E38 - E39
  • [24] Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC)
    Dobritoiu, Florin
    Baltan, Adelina
    Chefani, Alina
    Billingham, Kim
    Chenard, Marie-Pierrette
    Vaziri, Reza
    Lacroix-Triki, Magali
    Waydelich, Anne
    Erb, Gilles
    Andersson, Emilia
    Canamero, Marta
    Toro, Paula
    Wedden, Sarah
    D'Arrigo, Corrado
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (08) : 549 - 556
  • [25] PD-L1: an unavoidable biomarker in advanced triple-negative breast cancer
    Akiki, Mira
    Haddad, Fady Gh
    Kourie, Hampig Raphael
    Khaddage, Abir
    Smayra, Viviane Track
    BIOMARKERS IN MEDICINE, 2019, 13 (18) : 1539 - 1541
  • [26] The risk of PD-L1 expression misclassification in triple-negative breast cancer
    Shani Ben Dori
    Asaf Aizic
    Asia Zubkov
    Shlomo Tsuriel
    Edmond Sabo
    Dov Hershkovitz
    Breast Cancer Research and Treatment, 2022, 194 : 297 - 305
  • [27] External quality assessment for PD-L1 testing in triple negative breast cancer
    Warrick, N.
    Khalid, S.
    Dodson, A.
    Parry, S.
    VIRCHOWS ARCHIV, 2020, 477 : S55 - S55
  • [28] Eradication of triple negative breast cancer by in situ immunomodulation with PD-L1 blockade
    Oba, Takaaki
    Keler, Tibor
    Marsh, Henry
    Ito, Ken-ichi
    Ito, Fumito
    CANCER SCIENCE, 2021, 112 : 404 - 404
  • [29] JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer
    Chen, M.
    Pockaj, B.
    Andreozzi, M.
    Barrett, M. T.
    Ocal, I. T.
    McCullough, A. E.
    Krishna, S.
    Anderson, K. S.
    CANCER RESEARCH, 2017, 77
  • [30] (-)-Sativan Inhibits Tumor Development and Regulates miR-200c/PD-L1 in Triple Negative Breast Cancer Cells
    Peng, Fu
    Xiong, Liang
    Peng, Cheng
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345